Shuddha Guggulu in classical Ayurveda

What it is

Guggulu is the oleo-gum-resin tapped from the stem of Commiphora mukul Hook. ex Stocks (syn. C. wightii), a thorny shrub of the Burseraceae family native to India and adjacent dry regions. The fragrant yellow latex solidifies as it oozes out (Drugs.com clinical overview). Shuddha guggulu ("purified guggulu") is that raw resin after it has undergone shodhana: the classical Ayurvedic purification process described below. Raw resin is never used directly in classical pharmacy; only the purified form goes into formulations. (For the unpurified drug and its formulations, see our Guggulu article: this page focuses on the purification process and the purified form.)

The resin's best-studied constituents are the guggulsterones (E- and Z-stereoisomers), plant sterols that act as antagonist ligands for the bile-acid receptor FXR, which is involved in cholesterol and bile-acid metabolism (Drugs.com).

Classical properties

• Taste (rasa): bitter (Tikta), pungent (Katu)
• Qualities (guna): light (Laghu), sharp (Tikshna)
• Potency (virya): warming (Ushna)
• After digestion (vipaka): pungent (Katu)
• Doshas: traditionally said to settle Kapha and Vata; may increase Pitta

Traditional use

Purified guggulu is the base of classical formulations such as Yogaraja Guggulu, Triphala Guggulu, and Kaishora Guggulu, and has been used in Ayurveda for centuries, "most notably [for] arthritis, and as a weight-reducing agent in obesity". Other traditional uses include liver dysfunction, tumors, ulcers and sores, urinary complaints, edema, and seizures (Drugs.com history section). These are traditional uses, not clinical proof; the research is assessed below.

What research has looked at

Cholesterol

The headline trial is American. In a US randomized, double-blind, placebo-controlled trial of standardized guggulipid, LDL cholesterol increased in the guggul group rather than falling, and skin rashes were reported with guggul use (Drugs.com clinical summary).

A later trial was no kinder: in the 2020 TRIGU randomized, double-blind, placebo-controlled trial (n=90), three months of guggulu plus triphala "did not show better effects than placebo" on total or LDL cholesterol, BMI, or waist circumference, with hypersensitivity rash in 4.3% of the intervention group (Donato et al. 2020). An earlier small randomized trial (34 completers) found total cholesterol and HDL reduced versus placebo but LDL unchanged, with gastrointestinal discomfort, possible thyroid effects, and one rash-related withdrawal (2008 trial, via Epistemonikos).

The overall verdict from evidence summaries: "Until larger, long-term quality trials have been conducted and the incidence of adverse events clarified, C. mukul extracts cannot be routinely recommended for the management of hyperlipidemia" (Drugs.com). Notably, guggul was approved in India as a hypolipidemic drug in 1986 on the basis of earlier Indian trials: most of them small and of limited quality (Drugs.com).

Osteoarthritis (small trial)

One small clinical study in 30 elderly patients with knee osteoarthritis found that a standardized C. mukul extract significantly improved WOMAC and visual-analog pain scores: though not all outcome measures had improved at the 2-month point (Drugs.com, citing the trial). Preliminary, not proof.

Thyroid (pilot)

An open-label, randomized, comparative pilot trial of Vyoshadi Guggulu (a shuddha-guggulu-containing classical formulation) in subclinical hypothyroidism reported reductions in serum TSH and BMI with no observed adverse effects: but the authors themselves call for a larger randomized trial to confirm (PMC). This tested a compound formulation, not shuddha guggulu alone.

What the evidence does not support (yet)

What the trial data do not support: cholesterol-lowering, weight loss, and "detox" claims for guggul. The best-controlled trials show no meaningful lipid benefit, and no human trials have tested classically purified shuddha guggulu itself against placebo.

The shodhana (purification) process

Classical texts require guggulu to be purified before medicinal use, to remove physical impurities (stone, bark, wood fragments) and to reduce the adverse effects attributed to its intense pitta-aggravating action (narrative review of guggulu formulations, IJCAP). A published laboratory preparation of Maha Yograja Guggulu documents the procedure as actually performed, following the Ayurvedic Formulary of India (Part 1):

• Raw guggulu is broken into small pieces, with visible impurities removed by hand, and bundled into a cloth pottali.
• The bundle is suspended (dola yantra) in a vessel of boiling triphala decoction (kashaya) and simmered at around 80°C until the resin fully dissolves into the liquid.
• The liquid is filtered through a fine mesh (No. 60) to remove insoluble impurities.
• The filtrate is heated and condensed down to a semisolid mass, then tray-dried at 50°C (Maha Yograja Guggulu preparation study, PMC).

Triphala decoction is the standard medium; classical variants use the decoction of Adhatoda vasica (vasaka) or cow's milk, followed by the same straining-and-condensation sequence (IJCAP review). Note that modern clinical trials of "guggul" generally used standardized solvent extracts (guggulipid), not this classical purified preparation: so trial results do not map one-to-one onto shuddha guggulu as traditionally prepared.

Safety notes

Purification is specifically intended to reduce adverse effects (IJCAP review), but trial data still show a meaningful side-effect profile. Reported adverse effects include gastrointestinal upset (diarrhea, nausea), hypersensitivity and skin rash, moderate-to-severe generalized cutaneous reactions occurred in 9% of participants in one guggulipid hyperlipidemia trial, plus headache, hiccough, and possible thyroid effects (Drugs.com). Case reports include acute eczematous reactions to oral guggul and one case of rhabdomyolysis in a patient previously sensitized to statins, so caution is warranted in people who have had adverse effects from statins (Drugs.com).

Interactions: guggul may decrease serum concentrations of diltiazem and propranolol: monitor therapy (Drugs.com). Pregnancy and breastfeeding: safety information is lacking: avoid use (Drugs.com). Anyone with thyroid disorders or on heart or blood-pressure medication should consult a clinician before use.

FAQs

What is shuddha guggulu?

Shuddha guggulu is purified Commiphora mukul resin: raw guggulu that has undergone classical shodhana (simmering in triphala decoction, filtering, and condensing) to remove impurities and reduce adverse effects (PMC preparation study). See our Guggulu article for the unpurified drug.

How is guggulu purified?

Raw resin is bundled in cloth, suspended in boiling triphala decoction (or vasaka decoction, or cow's milk), simmered until dissolved, filtered to remove insoluble impurities, then condensed and dried (PMC; IJCAP review).

Does shuddha guggulu lower cholesterol?

The best-controlled trials say probably not. A US randomized trial found LDL rose versus placebo on standardized guggulipid, and a 2020 trial of guggulu plus triphala showed no benefit over placebo (Drugs.com; Donato et al. 2020). Evidence summaries do not recommend it for hyperlipidemia.

What dose was used in studies?

Swastik does not suggest amounts. The right amount depends on the person, the preparation and the product, so check with a qualified Ayurvedic practitioner or your doctor before taking any herb.

Is shuddha guggulu safe?

Purification aims to reduce adverse effects, but trials still report GI upset, skin rash/hypersensitivity (up to 9% with cutaneous reactions in one trial), and possible thyroid effects (Drugs.com). Avoid in pregnancy (no safety data) and use caution with heart/blood-pressure drugs: it may lower blood levels of diltiazem and propranolol.

Can guggulu be taken with statins?

Be cautious: a case report describes rhabdomyolysis in a guggul user previously sensitized to statins, and evidence summaries advise caution in people who have had adverse effects from statins (Drugs.com). Discuss it with your clinician first.

Sources

• Chaudhary A et al. "Application of spectroscopic and chromatographic methods for chemical characterization of an Ayurvedic herbo-mineral preparation: Maha Yograja Guggulu." (guggulu processing per the Ayurvedic Formulary of India, Part 1) — PMC · PMC5871055
• "Narrative review of guggulu formulations of Ayurveda reflecting their percentage of guggulu, pharmaceutics and pharmacology." IP Int J Comprehensive & Advanced Pharmacology — ijcap.in
• Drugs.com — "Guggul Uses, Benefits & Dosage" (clinical overview, medically reviewed, updated Dec 2025) — drugs.com
• Donato F et al. "Guggulu and Triphala for the treatment of hypercholesterolaemia: a placebo-controlled, double-blind, randomised trial." (TRIGU) 2020 — magistralbr.caldic.com
• "Resin from the mukul myrrh tree, guggul, can it be used for treating hypercholesterolemia? A randomized, controlled study." 2008 (via Epistemonikos) — epistemonikos.org
• "Efficacy of Vyoshadi Guggulu and Shadushana Churna in the management of subclinical hypothyroidism: an open labelled randomized comparative pilot clinical trial." PMC — PMC · PMC8966764

Disclaimer

This article is for educational purposes only and is not medical advice. Herbal products can interact with medications and are not suitable for everyone. Talk to a qualified healthcare practitioner before use — especially if you are pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.